Has Belinda Longmore received payments from drug or device companies?

Yes. Drug and device makers reported $4,097 in general payments to Belinda Longmore across 107 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Belinda Longmore did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Belinda Longmore come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Belinda Longmore

Psychiatry · Toledo, OHNPI 1306481502

Payments from drug & device makers

$4,097in general payments, 2019–2025

Across 107 payments — averaging $38.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$626
Otsuka America Pharmaceutical, Inc.$432
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$319
Neurocrine Biosciences, Inc.$307
Alkermes, Inc.$277
Acadia Pharmaceuticals Inc$234
plus $2K from 23 others

What the payments were for

Food & beverage$4,097100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	21	$626
Otsuka America Pharmaceutical, Inc.	10	$432
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	11	$319
Neurocrine Biosciences, Inc.	5	$307
Alkermes, Inc.	5	$277
Acadia Pharmaceuticals Inc	2	$234
Teva Pharmaceuticals USA, Inc.	5	$230
Axsome Therapeutics, Inc.	12	$161
Bioventus LLC	2	$155
Jazz Pharmaceuticals Inc.	2	$144
Eisai Inc.	1	$125
Gilead	1	$124
Avanir Pharmaceuticals, Inc.	1	$123
AstraZeneca	1	$121
Sage Therapeutics, LLC	1	$112
Biogen	2	$88
Lilly USA, LLC	1	$82
Johnson & Johnson	4	$76
Takeda Pharmaceuticals U.S.A., Inc.	4	$72
Ironshore Pharmaceuticals Inc.	3	$58
Phathom Pharmaceuticals, Inc.	3	$48
Collegium Pharmaceutical, Inc.	2	$35
Progenics Pharmaceuticals, Inc.	2	$33
Harmony Biosciences LLC	1	$26
Averitas Pharma Inc.	1	$20
Lundbeck LLC	1	$20
E.r. Squibb & Sons, L.L.C.	1	$19
Endo USA, Inc.	1	$18
Supernus Pharmaceuticals, Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,097 in reported general payments places this provider in the 85th percentile of 1,119 psychiatry providers in Ohio.

See all psychiatry providers in Ohio →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Mirtazapine	14	$422
Quetiapine Fumarate	11	$94
Alprazolam	29	$79
Bupropion XlBupropion Hcl	15	$64
Trazodone Hcl	24	$51

Paid to pharmacies, not to this prescriber.

Other psychiatry in Toledo

David JahnToledo$519K
Shishuka MalhotraCanton$15M
Henry NasrallahCincinnati$3.8M
Otto DuenoDayton$3.1M
Diab AlmhanaAvon Lake$2.7M
Mohamed Abdel AzizWest Chester$2.6M
Fred RomeoColumbus$2.3M
Mark WoyshvilleMiddleburg Heights$2.2M
Amita PatelDayton$2.1M
Caleb AdlerCincinnati$2M

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →